Literature DB >> 18671975

Calcium pentosan polysulfate directly inhibits enzymatic activity of ADAMTS4 (aggrecanase-1) in osteoarthritic chondrocytes.

Masayuki Takizawa1, Taku Yatabe, Aiko Okada, Miyuki Chijiiwa, Satsuki Mochizuki, Peter Ghosh, Yasunori Okada.   

Abstract

Aggrecanases that include ADAMTS1, 4, 5, 8, 9 and 15 are considered to play key roles in aggrecan degradation in osteoarthritic cartilage. Here we demonstrate that calcium pentosan polysulfate (CaPPS) directly inhibits the aggrecanase activity of ADAMTS4 without affecting the mRNA expression of the ADAMTS species in interleukin-1alpha-stimulated osteoarthritic chondrocytes. Synthetic peptides corresponding to specific regions of the thrombospondin type 1 repeat, cysteine-rich or spacer domain of ADAMTS4 inhibit the binding to immobilized CaPPS. These data suggest that CaPPS could function as chondroprotective agent for the treatment of osteoarthritis by inhibition of ADAMTS4 through interaction with the C-terminal ancillary domain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18671975     DOI: 10.1016/j.febslet.2008.07.036

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Sodium pentosan polysulfate resulted in cartilage improvement in knee osteoarthritis--an open clinical trial.

Authors:  Kenji Kumagai; Susumu Shirabe; Noriaki Miyata; Masakazu Murata; Atsushi Yamauchi; Yasuhumi Kataoka; Masami Niwa
Journal:  BMC Clin Pharmacol       Date:  2010-03-28

Review 2.  Action mechanisms of complementary and alternative medicine therapies for rheumatoid arthritis.

Authors:  Imada Keisuke; Bao-lin Bian; Xiang-dong Li; Sato Takashi; Ito Akira
Journal:  Chin J Integr Med       Date:  2011-10       Impact factor: 1.978

Review 3.  A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.

Authors:  Sheng Zhong; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2019-03-21       Impact factor: 5.858

4.  Pentosan Polysulfate: a Novel Glycosaminoglycan-Like Molecule for Effective Treatment of Alphavirus-Induced Cartilage Destruction and Inflammatory Disease.

Authors:  Lara J Herrero; Suan-Sin Foo; Kuo-Ching Sheng; Weiqiang Chen; Mark R Forwood; Richard Bucala; Suresh Mahalingam
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

5.  ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.

Authors:  HaiFeng Yang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2022-01-24

Review 6.  The role of ADAMTSs in arthritis.

Authors:  Edward A Lin; Chuan-Ju Liu
Journal:  Protein Cell       Date:  2010-02-07       Impact factor: 14.870

7.  Pentosan polysulfate promotes proliferation and chondrogenic differentiation of adult human bone marrow-derived mesenchymal precursor cells.

Authors:  Peter Ghosh; Jiehua Wu; Susan Shimmon; Andrew Cw Zannettino; Stan Gronthos; Silviu Itescu
Journal:  Arthritis Res Ther       Date:  2010-02-18       Impact factor: 5.156

8.  Pentosan polysulfate: a novel therapy for the mucopolysaccharidoses.

Authors:  Edward H Schuchman; Yi Ge; Alon Lai; Yury Borisov; Meghan Faillace; Efrat Eliyahu; Xingxuan He; James Iatridis; Helen Vlassara; Gary Striker; Calogera M Simonaro
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

9.  Pentosan polysulfate decreases myocardial expression of the extracellular matrix enzyme ADAMTS4 and improves cardiac function in vivo in rats subjected to pressure overload by aortic banding.

Authors:  Maria Vistnes; Jan Magnus Aronsen; Ida G Lunde; Ivar Sjaastad; Cathrine R Carlson; Geir Christensen
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

10.  Inhibitory effects of sodium pentosan polysulfate on formation and function of osteoclasts derived from canine bone marrow.

Authors:  H M Suranji Wijekoon; Eugene C Bwalya; Jing Fang; Sangho Kim; Kenji Hosoya; Masahiro Okumura
Journal:  BMC Vet Res       Date:  2018-05-02       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.